NSEAnalysts/Institutional Investor Meet/Con. Call Updates2d ago · 10 Nov 2026, 04:06 pm
Analysts/Institutional Investor Meet/Con. Call Updates
Global Health Limited · MEDANTA
✦ AI SummaryMgmt Change
Global Health Limited has informed the Exchange about a scheduled meeting with investors and analysts on November 19 and 20, 2026.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk5/10
Liquidity Impact8/10
Market Sentiment6/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Global Health Limited has informed the Exchange about Schedule of meet
Attachments (1)
📄pdf
Download →
MEDANTA21_10112026160417_GHLANALYSTSMEETNOVEMBER102026_SIGNED.pdf
View document text
Date: November 10, 2026
Ref:- GHL/2026-27/EXCH/ 77
The General Manager The Manager
Dept. of Corporate Services Listing Department
BSE Limited, P J Towers, Dalal National Stock Exchange of India Limited
Street, Mumbai - 400 001, India. Exchange Plaza, C-1, Block G, Bandra Kurla
Complex,Bandra (E), Mumbai - 400 051, India.
Scrip Code: 543654 Symbol: MEDANTA
Sub: Intimation for Schedule of Analyst/Institutional Investor Meeting.
Dear Sir(s),
Pursuant to Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements)
Regulations, 2015, we would like to inform you that the Company’s Management will meet
Investors/Analysts as per the below schedule:
Date of Meeting Name of Investor/Analyst Firm Type of Meeting Mode of Meeting
November 19, 2026 HSBC Global Asset Management One to One In Person
Veritas Asset Management One to One In Person
Schroders Investment Management One to One In Person
WFM Asia One to One In Person
CI Global Asset Management' One to One In Person
November 20, 2026 Wellington Management One to One In Person
Invesco One to One In Person
Fidelity Management & Research One to One In Person
Mirae Asset Global Investments One to One In Person
Please note that, no Unpublished Price Sensitive Information is proposed to be shared, thereat.
Note: Please note that the above meeting is subject to change in case of any unforeseen circumstances, on
the part of Analysts/Investors/Company.
Kindly take the above on record.
For Global Health Limited
Rahul Ranjan
Company Secretary & Compliance Officer
M. No. A17035
Regd. Office: E-18, Defence Colony, New Delhi 110024, Ph No.011- 44114411 www.medanta.org, info@medanta.org, CIN: L85110DL2004PLC128319